• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在阿尔茨海默病转基因动物模型中有效的γ-分泌酶抑制剂的发现。

Discovery of gamma-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease.

作者信息

Asberom Theodros, Zhao Zhiqiang, Bara Thomas A, Clader John W, Greenlee William J, Hyde Lynn A, Josien Hubert B, Li Wei, McPhail Andrew T, Nomeir Amin A, Parker Eric M, Rajagopalan Murali, Song Lixin, Wong Gwendolyn T, Zhang Lili, Zhang Qi, Pissarnitski Dmitri A

机构信息

Department of Chemical Research, Schering-Plough Research Institute, 2015 Galloping Hill Road, Kenilworth, NJ 07033, USA.

出版信息

Bioorg Med Chem Lett. 2007 Jan 15;17(2):511-6. doi: 10.1016/j.bmcl.2006.10.011. Epub 2006 Oct 10.

DOI:10.1016/j.bmcl.2006.10.011
PMID:17079141
Abstract

Attachment of the cyclopropylcarbamate group to the piperidine core of gamma-secretase inhibitors leads to a dramatic increase of their in vitro potency. Strategies for subsequent improvement of the in vivo pharmacokinetic profile of the series are discussed. Resulting compounds significantly reduce Abeta levels in TgCRND8 mice after a single PO dosing at 30 mpk.

摘要

将环丙基氨基甲酸酯基团连接到γ-分泌酶抑制剂的哌啶核心上会导致其体外效力显著提高。讨论了该系列化合物随后改善体内药代动力学特征的策略。所得化合物在以30mg/kg的剂量单次口服给药后,可显著降低TgCRND8小鼠脑中的β-淀粉样蛋白(Aβ)水平。

相似文献

1
Discovery of gamma-secretase inhibitors efficacious in a transgenic animal model of Alzheimer's disease.在阿尔茨海默病转基因动物模型中有效的γ-分泌酶抑制剂的发现。
Bioorg Med Chem Lett. 2007 Jan 15;17(2):511-6. doi: 10.1016/j.bmcl.2006.10.011. Epub 2006 Oct 10.
2
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的Notch-1保留型γ-分泌酶抑制剂贝加西他的发现。
J Med Chem. 2008 Dec 11;51(23):7348-51. doi: 10.1021/jm801252w.
3
Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.口服一种强效且选择性的非肽类β-分泌酶1(BACE-1)抑制剂可在体内降低淀粉样前体蛋白的β切割及β淀粉样蛋白的生成。
J Neurochem. 2007 Feb;100(3):802-9. doi: 10.1111/j.1471-4159.2006.04260.x.
4
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.贝加西他(GSI-953):一种新型的、选择性的噻吩磺酰胺类淀粉样前体蛋白γ-分泌酶抑制剂,用于治疗阿尔茨海默病。
J Pharmacol Exp Ther. 2009 Nov;331(2):598-608. doi: 10.1124/jpet.109.152975. Epub 2009 Aug 11.
5
Dynamics of Abeta turnover and deposition in different beta-amyloid precursor protein transgenic mouse models following gamma-secretase inhibition.γ-分泌酶抑制后不同β-淀粉样前体蛋白转基因小鼠模型中β-淀粉样蛋白周转和沉积的动力学
J Pharmacol Exp Ther. 2008 Nov;327(2):411-24. doi: 10.1124/jpet.108.140327. Epub 2008 Aug 7.
6
Pharmacological evidences for DFK167-sensitive presenilin-independent gamma-secretase-like activity.DFK167敏感的早老素非依赖性γ-分泌酶样活性的药理学证据。
J Neurochem. 2009 Jul;110(1):275-83. doi: 10.1111/j.1471-4159.2009.06131.x. Epub 2009 Apr 29.
7
Small conformationally restricted piperidine N-arylsulfonamides as orally active gamma-secretase inhibitors.作为口服活性γ-分泌酶抑制剂的小的构象受限哌啶N-芳基磺酰胺
Bioorg Med Chem Lett. 2007 Oct 1;17(19):5330-5. doi: 10.1016/j.bmcl.2007.08.013. Epub 2007 Aug 15.
8
Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouse.在CRND8小鼠中研究γ-分泌酶抑制剂N2-[(2S)-2-(3,5-二氟苯基)-2-羟基乙酰基]-N1-[(7S)-5-甲基-6-氧代-6,7-二氢-5H-二苯并[b,d]氮杂卓-7-基]-L-丙氨酰胺(LY411,575)的体内治疗窗。
J Pharmacol Exp Ther. 2006 Dec;319(3):1133-43. doi: 10.1124/jpet.106.111716. Epub 2006 Aug 31.
9
Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.新型杂环磺酰胺γ-分泌酶抑制剂的合成及其构效关系
Bioorg Med Chem. 2009 Jul 1;17(13):4708-17. doi: 10.1016/j.bmc.2009.04.052. Epub 2009 May 3.
10
Structural optimization of a CXCR2-directed antagonist that indirectly inhibits gamma-secretase and reduces Abeta.靶向 CXCR2 的拮抗剂的结构优化,间接抑制 γ-分泌酶并减少 Abeta。
Bioorg Med Chem. 2009 Dec 1;17(23):8102-12. doi: 10.1016/j.bmc.2009.09.051. Epub 2009 Oct 3.

引用本文的文献

1
Octodon degus: a model for the cognitive impairment associated with Alzheimer's disease.八齿鼠:与阿尔茨海默病相关认知障碍的模型。
CNS Neurosci Ther. 2013 Sep;19(9):643-8. doi: 10.1111/cns.12125. Epub 2013 May 27.
2
In Vivo Characterization of a Novel γ-Secretase Inhibitor SCH 697466 in Rodents and Investigation of Strategies for Managing Notch-Related Side Effects.新型γ-分泌酶抑制剂SCH 697466在啮齿动物体内的特性研究及管理Notch相关副作用策略的探究
Int J Alzheimers Dis. 2013;2013:823528. doi: 10.1155/2013/823528. Epub 2013 Mar 14.
3
Recent rodent models for Alzheimer's disease: clinical implications and basic research.
阿尔茨海默病的最新啮齿动物模型:临床意义和基础研究。
J Neural Transm (Vienna). 2012 Feb;119(2):173-95. doi: 10.1007/s00702-011-0731-5. Epub 2011 Nov 16.
4
DHA supplemented in peptamen diet offers no advantage in pathways to amyloidosis: is it time to evaluate composite lipid diet?在 Peptamen 饮食中添加 DHA 并没有在淀粉样变性途径中提供优势:是否是时候评估复合脂质饮食了?
PLoS One. 2011;6(9):e24094. doi: 10.1371/journal.pone.0024094. Epub 2011 Sep 8.
5
Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease.淀粉样前体蛋白选择性 γ-分泌酶抑制剂治疗阿尔茨海默病。
Alzheimers Res Ther. 2010 Dec 29;2(6):36. doi: 10.1186/alzrt60.
6
Preventive effect of Notch signaling inhibition by a gamma-secretase inhibitor on peritoneal dialysis fluid-induced peritoneal fibrosis in rats.- Notch 信号抑制对 γ-分泌酶抑制剂在大鼠腹膜透析液诱导的腹膜纤维化中的预防作用。
Am J Pathol. 2010 Feb;176(2):650-9. doi: 10.2353/ajpath.2010.090447. Epub 2010 Jan 7.